A 6-year-old girl with Gianotti-Crosti syndrome, which appeared to be caused by a reactivation of Epstein-Barr virus (EBV), is presented. The patient had had infectious mononucleosis at the age of 3 years. Since the titer of anti-EBV capsid antigen antibody was high at 1,280 and the titer of early antigen DR IgG, which increases during the early stage or reactivation, was high at 80 during the recovery stage, the patient was diagnosed as having Gianotti-Crosti syndrome associated with reactivation of EBV. Its clinical symptoms associated with reactivation of EBV were similar to those of that associated with primary EBV infection, in that the present patient had acrolocated papulovesicular dermatitis, superficial lymph node enlargement and mild hepatopathy. This patient provides valuable information in that reactivation was also observed with EBV like other types of herpesvirus.

Gianotti F: Viral anicteric hepatitis in infantile popular acrodermatitis. Hepatologica 1966;12:171–191.
Gianotti F: Papular acrodermatitis of childhood. Arch Dis Child 1973;48:794–799.
Joaquin VHS, Marks MI: Gianotti disease or Gianotti-Crosti syndrome? J Pediatr 1982;101:217–218.
Konno M, Kikuta H, Ishikawa N, Takada K, Iwanaga M, Osato T: A possible association between hepatitis-B antigen-negative infantile popular acrodermatitis and Epstein-Bar virus infection. J Pediatr 1982;101:222–224.
Rogers S, Connolly JH: Gianotti-Crosti syndrome and viral infection. Br Med J 1974;30:529.
James WD, Odom RB, Hatch MH: Gianotti-Crosti-like eruption associated with coxsackievirus A-16 infection. J Am Acad Dermatol 1982;6:862–866.
Lesher JLJ: Cytomegalovirus infections and the skin. J Am Acad Dermatol 1988;18:1333–1338.
Borreda D, Palomera S, Gilbert B, Lienhardt A, de Lumley L: 24 cases of human parvovirus B19 infection in children. Ann Pediatr (Paris) 1992;39:543–549.
Blauvelt A, Turner ML: Gianotti-Crosti syndrome and human immunodeficiency virus infection. Arch Dermatol 1994;130:481–483.
Yasumoto S, Tsujita J, Imayama S, Hori Y: Case report: Gianotti-Crosti syndrome associated with human herpesvirus-6 infection. J Dermatol 1996;23:499–501.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.